Efficacy and safety of a new HMG-CoA reductase inhibitor, NK-104, in patients with hypertriglyceridemia — Randomized double-blind, cross-over placebo controlled study
- 31 July 2000
- journal article
- abstracts
- Published by Elsevier in Atherosclerosis
- Vol. 151 (1) , 73
- https://doi.org/10.1016/s0021-9150(00)80335-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: